Financhill
Back

Intensity Therapeutics Stock Predictions

Intensity Therapeutics Stock Forecast

  • Is Intensity Therapeutics Stock Undervalued?
    The current Intensity Therapeutics [INTS] share price is $0.33. The Score for INTS is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • INTS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Intensity Therapeutics Stock Go Up Next Year?

Data Unavailable

Intensity Therapeutics Stock Rating

Data Unavailable

Intensity Therapeutics Stock Price History

Is INTS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INTS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intensitytherapeutics.com

52-Week Data

52-Week High:
5.01
52-Week Low:
0.26

Prediction Charts

Market Cap:
6M
Price in USD:
0.33
Volume:
2.5M
Beta:
3.67

Technical Analysis

SMA50:
0.39
SMA100:
1.13
SMA200:
1.92
52-Wk Change:
-93.39%

Stock Predictions

  • Is Intensity Therapeutics stock public?
    Yes, Intensity Therapeutics is a publicly traded company.
  • What is the Intensity Therapeutics stock quote today?
    The Intensity Therapeutics stock price is 0.33 USD today.
  • How to buy Intensity Therapeutics stock online?
    You can buy Intensity Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 0.30 0.31 0.31 0.29
Jun-27 0.30 0.32 0.35 0.26
Jun-30 0.31 0.31 0.35 0.30
Jul-1 0.31 0.31 0.31 0.29
Jul-2 0.31 0.30 0.31 0.30
Jul-3 0.30 0.30 0.32 0.28
Jul-7 0.31 0.28 0.31 0.26
Jul-8 0.28 0.29 0.31 0.28
Jul-9 0.29 0.31 0.32 0.29
Jul-10 0.31 0.32 0.33 0.30
Jul-11 0.31 0.33 0.34 0.30
Jul-14 0.33 0.34 0.37 0.32
Jul-15 0.34 0.33 0.35 0.30
Jul-16 0.33 0.33 0.34 0.31

Intensity Therapeutics Earnings

Data Unavailable

Intensity Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.23 per share.

* Intensity Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.